Get started
VIKING THERAPEUTICS INC COM USD0.00001VIKING THERAPEUTICS INC COM USD0.00001VIKING THERAPEUTICS INC COM USD0.00001

VIKING THERAPEUTICS INC COM USD0.00001

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0VQA chart


Full chart

0VQA upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪6.75 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.94 USD
Net income (FY)
‪−85.89 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪107.95 M‬
Beta (1Y)
2.65

Employees


Employees (FY)
27
Change (1Y)
+6 +28.57%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−3.18 M‬ USD

About Viking Therapeutics, Inc.


Sector
Health Technology
CEO
Brian Lian
Headquarters
San Diego
Website
vikingtherapeutics.com
Founded
2012
FIGI
BBG00LJZ4457
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

0VQA news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0VQA is 56.46 USD — it has increased by 0.90% in the past 24 hours. Watch VIKING THERAPEUTICS INC COM USD0.00001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange VIKING THERAPEUTICS INC COM USD0.00001 stocks are traded under the ticker 0VQA.
0VQA stock has fallen by −9.39% compared to the previous week, the month change is a −10.21% fall, over the last year VIKING THERAPEUTICS INC COM USD0.00001 has showed a 433.70% increase.
We've gathered analysts' opinions on VIKING THERAPEUTICS INC COM USD0.00001 future price: according to them, 0VQA price has a max estimate of 164.00 USD and a min estimate of 80.00 USD. Watch 0VQA chart and read a more detailed VIKING THERAPEUTICS INC COM USD0.00001 stock forecast: see what analysts think of VIKING THERAPEUTICS INC COM USD0.00001 and suggest that you do with its stocks.
0VQA reached its all-time high on Feb 28, 2024 with the price of 99.30 USD, and its all-time low was 2.16 USD and was reached on May 24, 2022. View more price dynamics on 0VQA chart.
See other stocks reaching their highest and lowest prices.
0VQA stock is 8.44% volatile and has beta coefficient of 2.65. Track VIKING THERAPEUTICS INC COM USD0.00001 stock price on the chart and check out the list of the most volatile stocks — is VIKING THERAPEUTICS INC COM USD0.00001 there?
Today VIKING THERAPEUTICS INC COM USD0.00001 has the market capitalization of ‪6.75 B‬, it has increased by 8.46% over the last week.
Yes, you can track VIKING THERAPEUTICS INC COM USD0.00001 financials in yearly and quarterly reports right on TradingView.
VIKING THERAPEUTICS INC COM USD0.00001 is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
0VQA earnings for the last quarter are −0.22 USD per share, whereas the estimation was −0.24 USD resulting in a 9.42% surprise. The estimated earnings for the next quarter are −0.28 USD per share. See more details about VIKING THERAPEUTICS INC COM USD0.00001 earnings.
VIKING THERAPEUTICS INC COM USD0.00001 revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
0VQA net income for the last quarter is ‪−24.94 M‬ USD, while the quarter before that showed ‪−22.25 M‬ USD of net income which accounts for −12.09% change. Track more VIKING THERAPEUTICS INC COM USD0.00001 financial stats to get the full picture.
No, 0VQA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 14, 2024, the company has 27.00 employees. See our rating of the largest employees — is VIKING THERAPEUTICS INC COM USD0.00001 on this list?
Like other stocks, 0VQA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIKING THERAPEUTICS INC COM USD0.00001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VIKING THERAPEUTICS INC COM USD0.00001 technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VIKING THERAPEUTICS INC COM USD0.00001 stock shows the buy signal. See more of VIKING THERAPEUTICS INC COM USD0.00001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.